Clinical trial · Observational
Optical Tomographic Scanner for Skin Lesions
NCT02891291CI-TRIAL-00023959unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Optical coherence tomography is technology widely used in medicine. In this study, the investigators will use an optical tomographic scanner to scan skin tissue image.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Skin Cancer, Benign Skin Tumor, Inflammatory Skin Disease | Malignant Skin Neoplasm | ALIAS | 0.85 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- Skin tissue image obtained.
- timeFrame
- 1 week
- description
- Part of the skin specimen from surgery or biopsy will be scanned.
Secondary outcomes (1)
- measure
- Skin histopathology
- timeFrame
- 2 week
- description
- The skin specimen will be stained with hematoxylin and eosin. Histopathological pictures (or findings) will be obtained and correlate with the scanned images.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 20 Years
- Maximum age
- 100 Years
Show eligibility criteria text
Patient who receive skin biopsy or surgery due to skin cancers, benign skin diseases, or inflammatory skin diseases.
References
Publications (0)
Data not yet available
No reference posted for this study.